Cargando…
The Past, Present, and Future of Clinically Applied Chimeric Antigen Receptor-T-Cell Therapy
Immunotherapy represents the fourth pillar of cancer therapy after surgery, chemotherapy, and radiation. Chimeric antigen receptor (CAR)-T-cell therapy is an artificial immune cell therapy applied in clinical practice and is currently indicated for hematological malignancies, with cluster of differe...
Autores principales: | Fujiwara, Yuki, Kato, Toshiki, Hasegawa, Futoshi, Sunahara, Muha, Tsurumaki, Yoshie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876595/ https://www.ncbi.nlm.nih.gov/pubmed/35215319 http://dx.doi.org/10.3390/ph15020207 |
Ejemplares similares
-
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future
por: Srour, Samer A., et al.
Publicado: (2022) -
Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments
por: Soler, David C., et al.
Publicado: (2021) -
Chimeric antigen receptor T cells applied to solid tumors
por: Zhou, Zhongguo, et al.
Publicado: (2022) -
Chimeric Antigen Receptor T-Cells: The Future Is Now
por: Mchayleh, Wassim, et al.
Publicado: (2019) -
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
por: Heine, Renaud, et al.
Publicado: (2021)